Page last updated: 2024-08-25

dimethyl itaconate and Psoriasis

dimethyl itaconate has been researched along with Psoriasis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akira, S; Amarasinghe, GK; Apte, RS; Artyomov, MN; Auclair, K; Bambouskova, M; Biller, SA; Bregman, H; de Guzman Strong, C; Duncan, D; Gorvel, L; Hai, T; Huang, LH; Johnson, B; Johnson, K; Jovanovic, M; Keskin, A; Kim, H; Klechevsky, E; Korenfeld, D; Lampropoulou, V; Loginicheva, E; Mathyer, ME; Randolph, GJ; Roddy, TP; Santeford, A; Satoh, T; Sehgal, R; Sergushichev, A; Soares, MP; Stewart, KM1

Other Studies

1 other study(ies) available for dimethyl itaconate and Psoriasis

ArticleYear
Electrophilic properties of itaconate and derivatives regulate the IκBζ-ATF3 inflammatory axis.
    Nature, 2018, Volume: 556, Issue:7702

    Topics: Activating Transcription Factor 3; Animals; Cells, Cultured; Cytokines; Female; Gene Expression Regulation; Glutathione; Humans; I-kappa B Proteins; Inflammation; Interleukin-6; Keratinocytes; Macrophages; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Psoriasis; Stress, Physiological; Succinates; Toll-Like Receptors

2018